Skip to main content
Log in

Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels

  • Cardiovascular Diseases
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

C-reactive protein (CRP) was proposed as a stronger predictor of cardiovascular events than low-density lipoprotein cholesterol (LDL-C); however, these associations may differ between myocardial infarction (MI) and stroke. We compared statistically the associations of CRP and LDL-C levels with risk of MI versus stroke and examined to what extent consideration of CRP or LDL-C increases the population attributable fractions (PAFs) of MI and stroke beyond traditional risk factors among 27,548 subjects from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study in a case-cohort design. Among subjects without prior MI or stroke, 156 developed MI and 132 stroke during 6.0 years of follow-up. In adjusted competing risk analyses CRP was positively related to MI and stroke (P difference between endpoints = 0.55), whereas LDL-C was related to MI but not stroke (P difference between endpoints = 0.003). The PAF for smoking, diabetes, and hypertension combined was 0.76 for MI, and 0.58 for stroke. With additional consideration of CRP the PAFs were 0.80 and 0.68, while with addition of LDL-C the PAFs were 0.88 and 0.55. We conclude that CRP is equally strongly related to risk of MI and stroke, whereas LDL-C is related to risk of MI but not stroke. Consideration of LDL-C beyond smoking, diabetes and hypertension may increase the PAF of MI slightly more than CRP. In contrast, consideration of CRP but not of LDL-C may increase the PAF of stroke beyond these factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CHD:

Coronary heart disease

CI:

Confidence interval

CRP:

C-reactive protein

CVD:

Cardiovascular disease

EPIC:

European prospective investigation into cancer and nutrition

HDL-C:

High density lipoprotein cholesterol

ICD-10:

International classification of diseases, 10th revision

LDL-C:

Low density lipoprotein cholesterol

MI:

Myocardial infarction

MONICA:

Multinational monitoring of trends and determinants in cardiovascular disease

PAF:

Population attributable fraction

RR:

Relative risk

SD:

Standard deviation

WHO:

World Health Organization

References

  1. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107(3):499–511.

    Article  PubMed  Google Scholar 

  2. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Sander K, Smith CJ, Stefanini A, Weber D. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005;36(6):1316–29.

    Article  PubMed  CAS  Google Scholar 

  3. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347(20):1557–65.

    Article  PubMed  CAS  Google Scholar 

  4. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001;103(1):163–82.

    PubMed  CAS  Google Scholar 

  5. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88(1):15–9.

    Article  PubMed  CAS  Google Scholar 

  6. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005;112(1):25–31.

    Article  PubMed  CAS  Google Scholar 

  7. Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the “only 50%” myth. Jama 2003;290(7):947–9.

    Article  PubMed  Google Scholar 

  8. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. Jama 2003;290(7):891–7.

    Article  PubMed  Google Scholar 

  9. Keil U, Liese AD, Hense HW, Filipiak B, Doring A, Stieber J, Lowel H. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J 1998;19(8):1197–207.

    Article  PubMed  CAS  Google Scholar 

  10. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ. Prevalence of conventional risk factors in patients with coronary heart disease. Jama 2003;290(7):898–904.

    Article  PubMed  Google Scholar 

  11. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the “only-50%” myth. Arch Intern Med 2001;161(22):2657–60.

    Article  PubMed  CAS  Google Scholar 

  12. Boeing H, Wahrendorf J, Becker N. EPIC-Germany–A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999;43(4):195–204.

    Article  PubMed  CAS  Google Scholar 

  13. Kroke A, Bergmann M, Klipstein-Grobusch K, Boeing H. Obesity, body fat distribution and body build: their relation to blood pressure and prevalence of hypertension. Int J Obes Relat Metab Disord 1998;22(11):1062–70.

    Article  PubMed  CAS  Google Scholar 

  14. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999;52(12):1165–72.

    Article  PubMed  CAS  Google Scholar 

  15. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1–11.

    Article  Google Scholar 

  16. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90(1):583–612.

    PubMed  CAS  Google Scholar 

  17. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50(4):1064–72.

    Article  PubMed  CAS  Google Scholar 

  18. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005;162(10):975–82.

    Article  PubMed  Google Scholar 

  19. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995;51(2):524–32.

    Article  PubMed  CAS  Google Scholar 

  20. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Washington R, Smith SC Jr. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998;97(18):1876–87.

    PubMed  CAS  Google Scholar 

  21. National Cholesterol Education Program. Third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002;106(25):3143–421.

    Google Scholar 

  22. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974;99(5):325–32.

    PubMed  CAS  Google Scholar 

  23. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122(5):904–14.

    PubMed  CAS  Google Scholar 

  24. D’Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990;9(12):1501–15.

    Article  PubMed  CAS  Google Scholar 

  25. Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007;18(5): 571–9.

    Google Scholar 

  26. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48(4):817–838.

    Article  Google Scholar 

  27. Prospective studies collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995;346(8991–8992):1647–53.

    Google Scholar 

  28. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Bmj 2003;326(7404):1423.

    Article  PubMed  CAS  Google Scholar 

  29. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350(14):1387–97.

    Article  PubMed  CAS  Google Scholar 

  30. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory Markers and the Risk of Coronary Heart Disease in Men, Women. N Engl J Med 2004;351(25):2599–2610.

    Article  PubMed  CAS  Google Scholar 

  31. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006;48(11):2235–42.

    Article  PubMed  CAS  Google Scholar 

  32. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837–47.

    PubMed  CAS  Google Scholar 

  33. Walter SD. Effects of interaction, confounding and observational error on attributable risk estimation. Am J Epidemiol 1983;117(5):598–604.

    PubMed  CAS  Google Scholar 

  34. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22(10):1668–73.

    Article  PubMed  CAS  Google Scholar 

  35. Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med 2005;165(18):2063–8.

    Article  PubMed  CAS  Google Scholar 

  36. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988;128(6):1185–97.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Matthias B. Schulze and Dr. Eric B. Rimm for critical comments to the manuscript; Dr. Kerstin Klipstein-Grobusch, Wolfgang Fleischhauer, Ellen Kohlsdorf, and Wolfgang Bernigau for data collection and data coding; and all participants in EPIC for their invaluable contribution to the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Pischon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pischon, T., Möhlig, M., Hoffmann, K. et al. Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels. Eur J Epidemiol 22, 429–438 (2007). https://doi.org/10.1007/s10654-007-9141-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-007-9141-2

Keywords

Navigation